SCHEMBL650605

SCHEMBL650605

CCCCn1c(-c2ccccc2C)nc(Cl)c1CN(CCC(C)C)Cc1ccc2[nH]ncc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 5/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
S1PR1 P21453 1/20 0.34
CRHR1 P34998 1/20 0.32
ROCK2 O75116 4/20 0.32
ROCK1 Q13464 3/20 0.32
CDC7 O00311 2/20 0.32
MAP4K4 O95819 2/20 0.32
PIM1 P11309 2/20 0.32
PRKACA P17612 2/20 0.32
CDK2 P24941 2/20 0.32
GSK3B P49841 2/20 0.32
CLK4 Q9HAZ1 2/20 0.32
MKNK2 Q9HBH9 2/20 0.32
PLK4 O00444 1/20 0.32
AURKA O14965 1/20 0.32
RPS6KA5 O75582 1/20 0.32
PRKCG P05129 1/20 0.32
CDK1 P06493 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL648912 0.88 KMT2A (0.37) KMT2AMEN1CRHR1L3MBTL1
SCHEMBL650154 0.88 KMT2A (0.39) KMT2AMEN1CRHR1L3MBTL1
SCHEMBL648229 0.87 TRPA1 (0.39) TRPA1KMT2AMEN1S1PR1ROCK2
SCHEMBL652764 0.86 TRPA1 (0.38) TRPA1KMT2AMEN1S1PR1ROCK2
SCHEMBL648038 0.85 KMT2A (0.36) KMT2AMEN1CRHR1PRKCDL3MBTL1
SCHEMBL650190 0.84 ROCK2 (0.38) TRPA1ROCK2ROCK1
SCHEMBL1913104 0.82 C5AR1 (0.42) KMT2AMEN1CRHR1L3MBTL1
SCHEMBL647954 0.82 KMT2A (0.34) KMT2AMEN1L3MBTL1
SCHEMBL648120 0.82 SMPD1 (0.38) KMT2AMEN1CRHR1L3MBTL1
SCHEMBL649586 0.81 CALM1 (0.38) KMT2AMEN1CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
EP-1490343-A1 NEW ARYL IMIDAZOLES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS Neurogen Corporation (US) 2004-12-29 EP disclosed
WO-2003082829-A1 NEW ARYL IMIDAZOLES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2003-10-09 WO disclosed